+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Intensity Modulated Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5941799
Free Webex Call
10% Free customization

Lung Cancer is the fastest growing segment, North America is the largest market globally

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Intensity Modulated Radiotherapy Market, valued at USD 2.01 Billion in 2024, is projected to experience a CAGR of 5.61% to reach USD 2.79 Billion by 2030. Intensity Modulated Radiotherapy (IMRT) is an advanced radiation therapy technique that precisely delivers radiation to tumors by modulating the intensity of numerous small radiation beams, thereby conforming to the tumor shape and minimizing exposure to surrounding healthy tissues. The market's expansion is fundamentally driven by the escalating global incidence of various cancer types, coupled with increasing demand for effective and less toxic treatment modalities that improve patient quality of life.

Key Market Drivers

The global Intensity Modulated Radiotherapy market is significantly influenced by the escalating global incidence of cancer, which fundamentally drives the demand for advanced and precise treatment modalities. The rising number of new cancer diagnoses worldwide necessitates effective therapeutic options like IMRT to manage the growing patient population. According to the American Cancer Society, in April 2024, in its "Global Cancer Statistics, 2024" report, an estimated 20 million cancer cases were newly diagnosed in 2022, underscoring the substantial and expanding need for oncology services.

Key Market Challenges

The significant capital investment required for Intensity Modulated Radiotherapy (IMRT) equipment acquisition, installation, and ongoing maintenance directly impedes the growth of the global market. This substantial financial outlay creates a considerable barrier, especially for healthcare providers in developing economies where budgets are frequently constrained. The high initial purchase price of sophisticated IMRT systems, coupled with expenses for specialized facility infrastructure, comprehensive training for technical staff, and continuous servicing contracts, places a heavy burden on healthcare systems.

Key Market Trends

The shift towards hypofractionated Intensity Modulated Radiotherapy regimens represents a significant trend in the global market, driven by its ability to deliver higher radiation doses per fraction over a shorter treatment period. This approach enhances patient convenience by reducing the number of hospital visits and overall treatment duration, while potentially lowering healthcare costs and improving access to care. According to an ASTRO 2024 report, approximately 70% of patients with intermediate-risk prostate cancer in the U. S. received hypofractionated regimens, indicating a substantial adoption rate in this patient cohort. This widespread acceptance is further supported by clinical evidence.

Key Market Players Profiled:

  • Siemens Healthineers AG
  • Accuray Incorporated
  • Elekta GmbH
  • Iba LLC
  • Hitachi, Ltd.
  • Mevion Medical Systems B.V.
  • Koninklijke Philips N.V.
  • Raysearch Laboratories AB
  • Brainlab AG
  • HD Biosciences Co., Ltd.

Report Scope:

In this report, the Global Intensity Modulated Radiotherapy Market has been segmented into the following categories:

By Radiation Type:

  • Proton radiation
  • Electron radiation
  • Photon radiation
  • Carbon-lon radiation

By End User:

  • Hospital & Clinics
  • Ambulatory Surgical care
  • Others

By Application:

  • Prostate cancer
  • Lung cancer
  • Breast cancer
  • Brain cancer
  • Gynecological cancers
  • Gastrointestinal cancers
  • Other cancers

By Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intensity Modulated Radiotherapy Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:
  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Intensity Modulated Radiotherapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-lon radiation)
5.2.2. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
5.2.3. By Application (Prostate cancer, Lung cancer, Breast cancer, Brain cancer, Gynecological cancers, Gastrointestinal cancers, Other cancers)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Intensity Modulated Radiotherapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Radiation Type
6.2.2. By End User
6.2.3. By Application
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Intensity Modulated Radiotherapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Radiation Type
6.3.1.2.2. By End User
6.3.1.2.3. By Application
6.3.2. Canada Intensity Modulated Radiotherapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Radiation Type
6.3.2.2.2. By End User
6.3.2.2.3. By Application
6.3.3. Mexico Intensity Modulated Radiotherapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Radiation Type
6.3.3.2.2. By End User
6.3.3.2.3. By Application
7. Europe Intensity Modulated Radiotherapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Radiation Type
7.2.2. By End User
7.2.3. By Application
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Intensity Modulated Radiotherapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Radiation Type
7.3.1.2.2. By End User
7.3.1.2.3. By Application
7.3.2. France Intensity Modulated Radiotherapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Radiation Type
7.3.2.2.2. By End User
7.3.2.2.3. By Application
7.3.3. United Kingdom Intensity Modulated Radiotherapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Radiation Type
7.3.3.2.2. By End User
7.3.3.2.3. By Application
7.3.4. Italy Intensity Modulated Radiotherapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Radiation Type
7.3.4.2.2. By End User
7.3.4.2.3. By Application
7.3.5. Spain Intensity Modulated Radiotherapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Radiation Type
7.3.5.2.2. By End User
7.3.5.2.3. By Application
8. Asia Pacific Intensity Modulated Radiotherapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Radiation Type
8.2.2. By End User
8.2.3. By Application
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Intensity Modulated Radiotherapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Radiation Type
8.3.1.2.2. By End User
8.3.1.2.3. By Application
8.3.2. India Intensity Modulated Radiotherapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Radiation Type
8.3.2.2.2. By End User
8.3.2.2.3. By Application
8.3.3. Japan Intensity Modulated Radiotherapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Radiation Type
8.3.3.2.2. By End User
8.3.3.2.3. By Application
8.3.4. South Korea Intensity Modulated Radiotherapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Radiation Type
8.3.4.2.2. By End User
8.3.4.2.3. By Application
8.3.5. Australia Intensity Modulated Radiotherapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Radiation Type
8.3.5.2.2. By End User
8.3.5.2.3. By Application
9. Middle East & Africa Intensity Modulated Radiotherapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Radiation Type
9.2.2. By End User
9.2.3. By Application
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Intensity Modulated Radiotherapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Radiation Type
9.3.1.2.2. By End User
9.3.1.2.3. By Application
9.3.2. UAE Intensity Modulated Radiotherapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Radiation Type
9.3.2.2.2. By End User
9.3.2.2.3. By Application
9.3.3. South Africa Intensity Modulated Radiotherapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Radiation Type
9.3.3.2.2. By End User
9.3.3.2.3. By Application
10. South America Intensity Modulated Radiotherapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Radiation Type
10.2.2. By End User
10.2.3. By Application
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Intensity Modulated Radiotherapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Radiation Type
10.3.1.2.2. By End User
10.3.1.2.3. By Application
10.3.2. Colombia Intensity Modulated Radiotherapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Radiation Type
10.3.2.2.2. By End User
10.3.2.2.3. By Application
10.3.3. Argentina Intensity Modulated Radiotherapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Radiation Type
10.3.3.2.2. By End User
10.3.3.2.3. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Intensity Modulated Radiotherapy Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Siemens Healthineers AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Accuray Incorporated
15.3. Elekta GmbH
15.4. Iba LLC
15.5. Hitachi, Ltd.
15.6. Mevion Medical Systems B.V.
15.7. Koninklijke Philips N.V.
15.8. Raysearch Laboratories AB
15.9. Brainlab AG
15.10. HD Biosciences Co., Ltd.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Siemens Healthineers AG
  • Accuray Incorporated
  • Elekta GmbH
  • Iba LLC
  • Hitachi, Ltd.
  • Mevion Medical Systems B.V.
  • Koninklijke Philips N.V.
  • Raysearch Laboratories AB
  • Brainlab AG
  • HD Biosciences Co., Ltd.

Table Information